DSC3 and urinary bladder carcinoma: Although the sample sizes are small in this study and immunohistochemistry was performed using commercially available non-validated reagents, our results highlight the importance of the DSC3 marker in understanding the nature of immunological differences in bladder cancer subtypes and cancer prognosis.